NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD.

Natural killer (NK) cells rapidly reconstitute following allogeneic stem cell transplantation (allo-SCT), at the time when alloreactive T cell immunity is being established. We investigated very early NK cell reconstitution in 82 patients following T cell-depleted allo-SCT. NK cell number rapidly increased, exceeding T cell reconstitution such that the NK:T cell ratio was over 40 by day 14. NK cells at day 14 (NK-14) were donor-derived, intensely proliferating and expressed chemokine receptors targeted to lymphoid and peripheral tissue. Spontaneous production of the immunoregulatory cytokine IL-10 was observed in over 70% of cells and transcription of cytokines and growth factors was augmented. NK-14 cell number was inversely correlated with the incidence of grade II-IV acute graft versus host disease (GVHD). These findings reveal that robust reconstitution of immunoregulatory NK cells by day 14 after allo-SCT is an important determinant of the clinical outcome, suggesting that NK cells may suppress the development of the T cell-mediated alloreactive immune response through production of IL-10.

[1]  F. Claas,et al.  Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia , 2016, Science Translational Medicine.

[2]  G. Hill,et al.  Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation , 2016, Front. Immunol..

[3]  Y. Kodera,et al.  Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey , 2016, Bone Marrow Transplantation.

[4]  D. Doherty,et al.  Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon‐γ or interleukin‐10 are expanded in asymptomatic, E antigen‐negative patients with persistent hepatitis B virus infection , 2015, Journal of viral hepatitis.

[5]  S. Granjeaud,et al.  Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcome. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  M. Pasquini,et al.  Acute graft-versus-host disease: a bench-to-bedside update. , 2014, Blood.

[7]  Maria F. Fragoso,et al.  Proliferation Conditions Promote Intrinsic Changes in NK Cells for an IL-10 Response , 2014, The Journal of Immunology.

[8]  Xiao-jun Huang,et al.  Immune reconstitution after haploidentical hematopoietic stem cell transplantation. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  T. Fehniger,et al.  Cytokine activation induces human memory-like NK cells. , 2012, Blood.

[10]  A. Oxenius,et al.  IL-10 Suppression of NK/DC Crosstalk Leads to Poor Priming of MCMV-Specific CD4 T Cells and Prolonged MCMV Persistence , 2012, PLoS pathogens.

[11]  L. Moretta,et al.  Dendritic Cell Editing by Activated Natural Killer Cells Results in a More Protective Cancer-Specific Immune Response , 2012, PloS one.

[12]  A. Barrett,et al.  Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  Joseph C. Sun,et al.  Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection , 2011, The Journal of experimental medicine.

[14]  M. Caligiuri,et al.  Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.

[15]  M. Altfeld,et al.  IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection. , 2010, The Journal of clinical investigation.

[16]  I. Yakoub-Agha,et al.  Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse , 2010, Bone Marrow Transplantation.

[17]  C. Karp,et al.  Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells. , 2009, Cell host & microbe.

[18]  B. Sandmaier,et al.  Defining the intensity of conditioning regimens: working definitions. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[19]  J. Schold,et al.  The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease , 2008, Haematologica.

[20]  Antal Rot,et al.  CCR7 and its ligands: balancing immunity and tolerance , 2008, Nature Reviews Immunology.

[21]  E. Riley,et al.  IL-10: The Master Regulator of Immunity to Infection , 2008, The Journal of Immunology.

[22]  Marcela R. Uribe,et al.  Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia , 2007, Leukemia.

[23]  K. Rezvani,et al.  Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[24]  D. Tough,et al.  In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection , 2007, Immunology.

[25]  W. Shlomchik,et al.  Graft-versus-host disease , 2007, Nature Reviews Immunology.

[26]  P. Parham,et al.  The expanded cattle KIR genes are orthologous to the conserved single-copy KIR3DX1 gene of primates , 2007, Immunogenetics.

[27]  M. Mack,et al.  Gut-associated lymphoid tissue-primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine. , 2006, Blood.

[28]  L. Moretta,et al.  Early liaisons between cells of the innate immune system in inflamed peripheral tissues. , 2005, Trends in immunology.

[29]  L. Zitvogel,et al.  Natural-killer cells and dendritic cells: "l'union fait la force". , 2005, Blood.

[30]  Y. Sasaki,et al.  Cytokine Profile of Natural Killer Cells in Early Human Pregnancy , 2005, American journal of reproductive immunology.

[31]  A. Bacigalupo.  Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects , 2005, Bone Marrow Transplantation.

[32]  A. Svejgaard,et al.  Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[33]  L. Bisset,et al.  Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland , 2004, European journal of haematology.

[34]  J. Dorfman,et al.  Turnover and Proliferation of NK Cells in Steady State and Lymphopenic Conditions1 , 2004, The Journal of Immunology.

[35]  M. Farrar,et al.  In Vivo Survival and Homeostatic Proliferation of Natural Killer Cells , 2003, The Journal of experimental medicine.

[36]  M. Caligiuri,et al.  In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. , 2002, Blood.

[37]  Katia Perruccio,et al.  Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.

[38]  H. Ljunggren,et al.  Targeting of human dendritic cells by autologous NK cells. , 1999, Journal of immunology.

[39]  S. Rafii,et al.  The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. , 1998, Blood.

[40]  D. Taub,et al.  Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. , 1998, The Journal of clinical investigation.

[41]  H. Kanegane,et al.  Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. , 1998, Journal of immunology.

[42]  J. Klein,et al.  IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE , 1997, British journal of haematology.

[43]  R. Marcus,et al.  Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. , 1986, Bone marrow transplantation.

[44]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[45]  S. Orkin,et al.  Phenotype of recovering lymphoid cell populations after marrow transplantation , 1985, The Journal of experimental medicine.

[46]  G. Trinchieri,et al.  Human natural killer cells. , 1979, Transplantation proceedings.

[47]  P. Neiman,et al.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. , 1977, Blood.

[48]  M. Martelli,et al.  NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. , 2008, Blood cells, molecules & diseases.

[49]  L. Thomsen,et al.  Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. , 2004, Nature immunology.